Zhengye Biotechnology Holding Limited's Quiet Period To Expire on February 17th (NASDAQ:ZYBT)

Zhengye Biotechnology's (NASDAQ:ZYBT - Get Free Report) quiet period will end on Monday, February 17th. Zhengye Biotechnology had issued 1,500,000 shares in its public offering on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. During the company's quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Zhengye Biotechnology Price Performance

Shares of Zhengye Biotechnology stock traded down $0.08 during mid-day trading on Tuesday, hitting $4.27. The stock had a trading volume of 6,820 shares, compared to its average volume of 129,523. Zhengye Biotechnology has a 12-month low of $3.70 and a 12-month high of $6.10.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.